Interventional-device firm Guidant has received Food and Drug Administration clearance for a new carotid stent system designed to reduce the risk of stroke associated with carotid artery disease.
The RX Acculink carotid stent system and RX Accunet embolic protection system provide a minimally invasive alternative to conventional open carotid artery surgery for patients at high surgical risk, according to the Indianapolis-based firm.
High-risk patients indicated for carotid stenting with Guidant's devices include those with significant heart, kidney, or lung disease; recurrence of a blockage following a prior carotid surgery; or with difficult-to-access neck anatomy, the company said.
By AuntMinnie.com staff writers
September 1, 2004
Related Reading
Guidant launches Voyager, July 27, 2004
Guidant books record Q2, July 23, 2004
Guidant gets CE Mark, May 27, 2004
Dollens to retire from Guidant helm, May 18, 2004
Guidant notches record Q1, April 22, 2004
Copyright © 2004 AuntMinnie.com
